7 May 2025 in Journal of the American Society of Nephrology
ANCA-associated vasculitis (AAV) is a rare and potentially fatal autoimmune disorder characterized by pauci-immune necrotizing vasculitis affecting small- to medium-sized blood vessels. The pathogenic role of ANCAs in AAV is supported by both clinical and experimental evidence, and when used in the proper clinical setting, ANCA testing is highly specific for AAV. Testing with both indirect immunofluorescence assay and enzyme immunoassay may increase sensitivity for AAV; however, testing with a high-quality enzyme immunoassay may be used alone. Nonvasculitic conditions and drugs can cause ANCA positivity without manifestations of AAV. We review ANCA testing itself, performance characteristics and specific conditions for the laboratory test, and various conditions when ANCA testing is useful in diagnosis, disease monitoring, and selecting treatment.
11 November 2025 in Journal of Intensive Care Medicine
Intravenous crystalloid solutions are among the most common medical interventions applied and have supplanted colloid-based solutions as the standard of care for volume resuscitation in most settings. Despite their widespread use, debate has existed over the optimal composition of these solutions and their differential effects on patient outcomes. In this review, we will describe the pre-clinical studies that identified physiological differences when ‘balanced crystalloids’ and ‘normal saline’ are administered, the experimental studies that confirmed these differences in humans, the observational studies that indicated the level of concern, and the subsequent clinical trials that provide evidence to guide therapy in current practice.